An multicenter study to evaluate the efficacy and tolerability of a 4-week therapy with the combination of valsartan 160mg + amlodipine 5mg in hypertensive patients not adequately responding to 4-week treatment with amlo [amlodipine] 5mg or felodipine 5mg in monotherapy.

Trial Profile

An multicenter study to evaluate the efficacy and tolerability of a 4-week therapy with the combination of valsartan 160mg + amlodipine 5mg in hypertensive patients not adequately responding to 4-week treatment with amlo [amlodipine] 5mg or felodipine 5mg in monotherapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2011

At a glance

  • Drugs Amlodipine; Valsartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 07 Nov 2011 Actual end date (Feb 2007) added as reported by ClinicalTrials.gov.
    • 07 Nov 2011 Actual patient number is 224 according to ClinicalTrials.gov.
    • 06 Jul 2007 Status change from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top